Fast and cloning-free CRISPR/Cas9-mediated genomic editing in mammalian cells
View / Open Files
Publication Date
2019-10-17Journal Title
Traffic
ISSN
1398-9219
Publisher
Wiley-Blackwell
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Manna, P., Davis, l., & Robinson, M. (2019). Fast and cloning-free CRISPR/Cas9-mediated genomic editing in mammalian cells. Traffic https://doi.org/10.1111/tra.12696
Abstract
CHoP-In (CRISPR/Cas9-mediated Homology-independent PCR-product integration) is a fast, non-homologous end-joining based, strategy for genomic editing in mammalian cells. There is no requirement for cloning in generation of the integration donor, instead the desired integration donor is produced as a PCR product, flanked by the Cas9 recognition sequences of the target locus. When co-transfected with the cognate Cas9 and guide RNA, double strand breaks are introduced at the target genomic locus and at both ends of the PCR product. This allows incorporation into the genomic locus via hon-homologous end joining. The approach is versatile, allowing N-terminal, C-terminal or internal tag integration and gives predictable genomic integrations, as demonstrated for a selection of well characterised membrane trafficking proteins. The lack of donor vectors offers advantages over existing methods in terms of both speed and hands-on time. As such this approach will be a useful addition to the genome editing toolkit of those working in mammalian cell systems.
Sponsorship
The CIMR is supported by Wellcome Trust Strategic Award 100140. LJD is supported by a BBSRC industrial CASE studentship with GSK Research and Development Ltd. MSR and PTM are supported by a Wellcome Trust PRFassociated Programme Grant to MSR (086598)
Identifiers
External DOI: https://doi.org/10.1111/tra.12696
This record's URL: https://www.repository.cam.ac.uk/handle/1810/298070
Recommended or similar items
The following licence files are associated with this item: